Uploaded April 2026 | Updated September 2026, 1 week ago
Angela Russell, DPhil, University of Oxford, 2021 Harrington UK Rare Disease Scholar, is developing small molecule drugs that boost utrophin, a protein that can compensate for missing dystrophin, offering a promising new treatment path for all patients with Duchenne muscular dystrophy. The Oxford-Harrington Rare Disease Centre is a transatlantic initiative dedicated to accelerating breakthrough treatments and cures for rare diseases. Learn more: OxfordHarrington.org.
Angela Russell, DPhil, University of Oxford, 2021 Harrington UK Rare Disease Scholar, is developing small molecule drugs that boost utrophin, a protein that can compensate for missing dystrophin, offering a promising new treatment path for all patients with Duchenne muscular dystrophy. The Oxford-Harrington Rare Disease Centre is a transatlantic initiative dedicated to accelerating breakthrough treatments and cures for rare diseases. Learn more: OxfordHarrington.org.
